Companies: 10,795·Total market cap: $144.5T
Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc

AVDLNASDAQHealthcare
$21.64
+$0.00(+0.00%)
Market Cap$2.1B
P/E Ratio
52W High$23.57
52W Low$6.38
Overview

Avadel Pharmaceuticals plc(AVDL)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · AVDL · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.17B$0.03B$0.00B$0.00B$0.02B
Cost of Revenue$0.02B$0.00B$0.00B$0.00B$0.01B
Gross Profit$0.15B$0.03B$0.00B$0.00B$0.02B
Gross Margin %(computed)90.97%96.97%74.29%
Operating Expenses
R&D Expenses$0.02B$0.01B$0.02B$0.02B$0.02B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.20B$0.16B$0.10B$0.09B$0.01B
Operating Income($0.04B)($0.14B)($0.10B)($0.09B)$0.01B
Operating Margin %(computed)-25.07%-492.97%26.04%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.01B
Income Before Tax($0.05B)($0.16B)($0.11B)($0.09B)($0.01B)
Income Tax Expense($0.00B)($0.00B)$0.03B($0.02B)($0.01B)
Net Income($0.05B)($0.16B)($0.14B)($0.08B)$0.01B
Net Margin %(computed)-28.87%-573.17%31.47%
Per Share & EBITDA
EPS (Basic)$-0.51$-2.00$-2.29$-1.32$0.13
Wtd Avg Shares0.10B0.08B0.06B0.06B0.05B
EBITDA($0.04B)($0.15B)($0.10B)($0.08B)$0.01B
EBITDA Margin %(computed)-21.03%-533.29%42.99%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Avadel Pharmaceuticals plc

关于Avadel Pharmaceuticals plc(AVDL)损益表

Avadel Pharmaceuticals plc(AVDL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,AVDL实现营收$0.17B,毛利润$0.15B(毛利率90.97%),净利润($0.05B)(净利率-28.87%)。

常见问题

AVDL · 4 问

Avadel Pharmaceuticals plc(AVDL)2024财年营收为$0.17B,同比up504.8%。

AVDL revenueAVDL salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08